Back
Edgewise Therapeutics Stock Price Chart
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Buy
58
EWTX
Edgewise Therapeutics
Last Price:
31.71
Seasonality Move:
66.43%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- The current trend is moderately bearish and EWTX is experiencing slight selling pressure.
Edgewise Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.13 | Sell |
| 20-day SMA: | 34.7 | Sell |
| 50-day SMA: | 28.88 | Buy |
| 200-day SMA: | 20.72 | Buy |
| 8-day EMA: | 34.41 | Sell |
| 20-day EMA: | 33.8 | Sell |
| 50-day EMA: | 30.01 | Buy |
| 200-day EMA: | 21.42 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 49.08 | Sell |
| Chaikin Money Flow: | -211632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.74 - 35.72) | Sell |
| Bollinger Bands (100): | (17.09 - 30.81) | Buy |
Edgewise Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 32.87 while EWTX 8-day simple moving average is 35.13, which is a Sell signal.
- The stock price of EWTX is 32.87 while Edgewise Therapeutics 20-day SMA is 34.70, which makes it a Sell.
- Edgewise Therapeutics 50-day simple moving average is 28.88 while EWTX share price is 32.87, making it a Buy technically.
- EWTX stock price is 32.87 and Edgewise Therapeutics 200-day simple moving average is 20.72, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Buy
58
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $32.87. The Score for EWTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
3.11B
Price in USD:
32.87
Share Volume:
517.68K
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
5.93
Buy
58
Edgewise Therapeutics (EWTX)
is a Buy
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?
The Edgewise Therapeutics stock price is 32.87 USD today. -
Will EWTX stock go up or go down?
Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Edgewise Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is not overvalued.
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 32.87 while EWTX 8-day exponential moving average is 34.41, which is a Sell signal.
- The stock price of EWTX is 32.87 while Edgewise Therapeutics 20-day EMA is 33.80, which makes it a Sell.
- Edgewise Therapeutics 50-day exponential moving average is 30.01 while EWTX share price is 32.87, making it a Buy technically.
- EWTX stock price is 32.87 and Edgewise Therapeutics 200-day simple moving average is 21.42, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
- EWTX Moving Average Covergence Divergence (MACD) indicator is 1.37, suggesting Edgewise Therapeutics is a Buy
- Edgewise Therapeutics Relative Strength Index (RSI) is 49.08, which suggest Edgewise Therapeutics is oversold
- The Bollinger Bands (25) for Edgewise Therapeutics is (32.74 - 35.72), which suggest Edgewise Therapeutics is a Buy
- The Bollinger Bands (100) for Edgewise Therapeutics is (17.09 - 30.81), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.